Protox doses first patient in Phase II trail of prostate drug
pharmaceutical-business-review.com     May 17, 2008            

Protox Therapeutics has announced the enrolment and successful dosing of the first patient in a Phase II clinical trial evaluating PRX302 to treat benign prostatic hyperplasia, or enlarged prostate, a common and bothersome urological condition that affects over one million men in Canada and over... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

Freezer empty; just wait

times-news.com     6 mins ago          

Another hunting season approaches and for this we give thanks and praise. A weekend ago, I went to the beer fridge, which doubles as the wild game freezer, and fished out the last of the dove breasts. The idea is to get the mix...                

comments

DialSimple Launches Phone Mapping Technology to Call Abroad Conveniently and at Low Cost

prnewsnow.com     1 hr ago          

Now save money and time by using phone mapping technology to make international calls at dirt cheap courtesy DialSimplecomNow no more hassles of cumbersome Calling Cards where one has to enter PIN and then punchin phone numbers...                

comments

                   

Web Host Industry Review Magazine July 08 Focuses on Security, SaaS

prweb.com     1 hr ago   1 related          

Hosting magazine covers the physical security issue and puts the software as a service discussion to a panel of experts. The Web Host Industry Review , the publication of record for the hosting business, is excited to announce...                

comments

                   

New Study Shows That Dehydration is Detrimental to Resistance Exercise Adaptations

prweb.com     1 hr ago          

Developing lean body mass and achieving body fat loss may be more difficult if you are dehydrated. A brand new study in the Journal of Applied Physiology reveals that being dehydrated can significantly impair the strength and...                

comments